These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7713553)

  • 21. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model.
    Kita Y; Tanaka T; Yoshida S; Ohara N; Kaneda Y; Kuwayama S; Muraki Y; Kanamaru N; Hashimoto S; Takai H; Okada C; Fukunaga Y; Sakaguchi Y; Furukawa I; Yamada K; Inoue Y; Takemoto Y; Naito M; Yamada T; Matsumoto M; McMurray DN; Cruz EC; Tan EV; Abalos RM; Burgos JA; Gelber R; Skeiky Y; Reed S; Sakatani M; Okada M
    Vaccine; 2005 Mar; 23(17-18):2132-5. PubMed ID: 15755583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models for experimental tuberculosis.
    Smith D; Wiegeshaus E; Balasubramanian V
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S68-70. PubMed ID: 11010825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental ocular tuberculosis in guinea pigs.
    Rao NA; Albini TA; Kumaradas M; Pinn ML; Fraig MM; Karakousis PC
    Arch Ophthalmol; 2009 Sep; 127(9):1162-6. PubMed ID: 19752425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence.
    Dambuza I; Allie N; Fick L; Johnston N; Fremond C; Mitchell J; Quesniaux VF; Ryffel B; Jacobs M
    Tuberculosis (Edinb); 2008 May; 88(3):221-34. PubMed ID: 17950671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse and guinea pig models for testing new tuberculosis vaccines.
    Orme IM
    Tuberculosis (Edinb); 2005; 85(1-2):13-7. PubMed ID: 15687022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-specific protection against pulmonary Legionella pneumophila infection in guinea-pigs immunized and challenged with mycobacteria.
    Gibson DH; Baskerville A; Ashworth LA; Fitzgeorge RB
    Br J Exp Pathol; 1985 Jun; 66(3):333-44. PubMed ID: 3924087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of vaccine-induced resistance in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Dai G; Phalen S
    Tuber Lung Dis; 1999; 79(4):261-6. PubMed ID: 10692995
    [No Abstract]   [Full Text] [Related]  

  • 28. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
    Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
    Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis: I. Basic Principles, II. Preclinical Testing, and III. Clinical Testing.
    Dannenberg AM; Dey B
    Vaccines (Basel); 2013 Jan; 1(1):58-76. PubMed ID: 26343850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental approaches to designing vaccines against tuberculous infection reactivation].
    Radaeva TV; Nikonenko BV; Kapina MA; Mishchenko VV; Apt AS
    Probl Tuberk Bolezn Legk; 2006; (5):45-8. PubMed ID: 16850924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathogenesis of post-primary tuberculosis. A game changer for vaccine development.
    Hunter R; Actor J
    Tuberculosis (Edinb); 2019 May; 116S():S114-S117. PubMed ID: 31076321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model.
    Gupta A; Ahmad FJ; Ahmad F; Gupta UD; Natarajan M; Katoch VM; Bhaskar S
    Vaccine; 2012 Sep; 30(43):6198-209. PubMed ID: 22871353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence for guinea pigs of tubercle bacilli isolated from the sputum of participants in the BCG trial, Chingleput District, South India.
    Prabhakar R; Venkataraman P; Vallishayee RS; Reeser P; Musa S; Hashim R; Kim Y; Dimmer C; Wiegeshaus E; Edwards ML
    Tubercle; 1987 Mar; 68(1):3-17. PubMed ID: 3116731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis.
    Dannenberg AM
    Immunobiology; 1994 Oct; 191(4-5):461-73. PubMed ID: 7713560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models of tuberculosis: Guinea pigs.
    Clark S; Hall Y; Williams A
    Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a018572. PubMed ID: 25524720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on thiacetazone resistance of tubercle bacilli. II. The relation between virulence in guinea-pigs and thiacetazone sensitivity of tubercle bacilli isolated from previously untreated tuberculous children].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 Apr; 46(4):83-7. PubMed ID: 4102104
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral delivery of BCG Moreau Rio de Janeiro gives equivalent protection against tuberculosis but with reduced pathology compared to parenteral BCG Danish vaccination.
    Clark SO; Kelly DL; Badell E; Castello-Branco LR; Aldwell F; Winter N; Lewis DJ; Marsh PD
    Vaccine; 2010 Oct; 28(43):7109-16. PubMed ID: 20708695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The virulence of tubercle bacilli for guinea pigs and the susceptibility of guinea pigs to tubercle bacilli.
    Wijsmuller G; Selin M; Long M
    Am Rev Respir Dis; 1970 Aug; 102(2):221-35. PubMed ID: 4988224
    [No Abstract]   [Full Text] [Related]  

  • 40. [Riddles in human tuberculous infection].
    Tsuyuguchi I
    Kekkaku; 2000 Oct; 75(10):603-9. PubMed ID: 11109776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.